Open Access

Advancements in the diagnosis and treatment of sub‑centimeter lung cancer in the era of precision medicine (Review)

  • Authors:
    • Xiao Wang
    • Jingwei Shi
    • Zhengcheng Liu
  • View Affiliations

  • Published online on: February 9, 2024     https://doi.org/10.3892/mco.2024.2726
  • Article Number: 28
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is the malignancy with the highest global mortality rate and imposes a substantial burden on society. The increasing popularity of lung cancer screening has led to increasing number of patients being diagnosed with pulmonary nodules due to their potential for malignancy, causing considerable distress in the affected population. However, the diagnosis and treatment of sub‑centimeter grade pulmonary nodules remain controversial. The evolution of genetic detection technology and the development of targeted drugs have positioned the diagnosis and treatment of lung cancer in the precision medicine era, leading to a marked improvement in the survival rate of patients with lung cancer. It has been established that lung cancer driver genes serve a key role in the development and progression of sub‑centimeter lung cancer. The present review aimed to consolidate the findings on genes associated with sub‑centimeter lung cancer, with the intent of serving as a reference for future studies and the personalized management of sub‑centimeter lung cancer through genetic testing.
View References

Related Articles

Journal Cover

April-2024
Volume 20 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang X, Shi J and Liu Z: Advancements in the diagnosis and treatment of sub‑centimeter lung cancer in the era of precision medicine (Review). Mol Clin Oncol 20: 28, 2024.
APA
Wang, X., Shi, J., & Liu, Z. (2024). Advancements in the diagnosis and treatment of sub‑centimeter lung cancer in the era of precision medicine (Review). Molecular and Clinical Oncology, 20, 28. https://doi.org/10.3892/mco.2024.2726
MLA
Wang, X., Shi, J., Liu, Z."Advancements in the diagnosis and treatment of sub‑centimeter lung cancer in the era of precision medicine (Review)". Molecular and Clinical Oncology 20.4 (2024): 28.
Chicago
Wang, X., Shi, J., Liu, Z."Advancements in the diagnosis and treatment of sub‑centimeter lung cancer in the era of precision medicine (Review)". Molecular and Clinical Oncology 20, no. 4 (2024): 28. https://doi.org/10.3892/mco.2024.2726